We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Clavis Pharma Announces Expansion Of ELACYT(TM) Clinical Development Program
Cancer / Oncology Clavis Pharma (OSE: CLAVIS) announced that it has received approval from the Belgian Authorities to initiate a new Phase II clinical study with ELACYT(TM) in ovarian cancer at the University Hospital of Leuven, with Professor Ignace Vergote as principal investigator. The study has also been approved by the Independent Review Board (IRB) at the Cancer Therapy and Research Center, San Antonio, USA, with Professor Tyler Curiel as principal investigator.
Custom Search
